Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1758053rdf:typepubmed:Citationlld:pubmed
pubmed-article:1758053lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1758053lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:1758053lifeskim:mentionsumls-concept:C0021760lld:lifeskim
pubmed-article:1758053lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:1758053lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:1758053lifeskim:mentionsumls-concept:C1550594lld:lifeskim
pubmed-article:1758053lifeskim:mentionsumls-concept:C1548760lld:lifeskim
pubmed-article:1758053lifeskim:mentionsumls-concept:C1547300lld:lifeskim
pubmed-article:1758053lifeskim:mentionsumls-concept:C0580822lld:lifeskim
pubmed-article:1758053pubmed:issue11lld:pubmed
pubmed-article:1758053pubmed:dateCreated1992-2-6lld:pubmed
pubmed-article:1758053pubmed:abstractTextA 58-year-old female was admitted to our hospital because of anemia in March 1987. Monoclonal protein (IgA, kappa) was detected and a diagnosis of multiple myeloma was made. Partial remission was obtained after VAD therapy with alpha-interferon. In December 1989, she was readmitted because of a pathological fracture of the left humerus. A white blood cell count was 4400/microliters with 30% myeloma cells and the urine protein (Bence Jones protein) was 26 g/day. Systemic chemotherapy was not effective. She developed pleural and pericardial effusions, bone mass, disturbance of consciousness and died of respiratory failure only 3 months after readmission. The pleural and pericardial fluids contained many myeloma cells. c-myc gene rearrangement was detected in myeloma cells obtained from the pleural fluid using c-myc exon1 and exon2 probes. The levels of interleukin-6 (IL-6) measured by ELISA was 107.4 pg/ml in serum, 56.2 pg/ml in pleural fluid and 780.0 pg/ml in pericardial fluid. Because of the lack of any overt infectious focus, the level of IL-6 appears to have been related to aggressive proliferation of myeloma cells. It was of interest that C-reactive protein, induced by IL-6, was a good marker reflecting disease activity.lld:pubmed
pubmed-article:1758053pubmed:languagejpnlld:pubmed
pubmed-article:1758053pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1758053pubmed:citationSubsetIMlld:pubmed
pubmed-article:1758053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1758053pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1758053pubmed:statusMEDLINElld:pubmed
pubmed-article:1758053pubmed:monthNovlld:pubmed
pubmed-article:1758053pubmed:issn0485-1439lld:pubmed
pubmed-article:1758053pubmed:authorpubmed-author:NawataHHlld:pubmed
pubmed-article:1758053pubmed:authorpubmed-author:AbeYYlld:pubmed
pubmed-article:1758053pubmed:authorpubmed-author:KatoSSlld:pubmed
pubmed-article:1758053pubmed:authorpubmed-author:TakeichiNNlld:pubmed
pubmed-article:1758053pubmed:authorpubmed-author:SakaiKKlld:pubmed
pubmed-article:1758053pubmed:authorpubmed-author:NishimuraJJlld:pubmed
pubmed-article:1758053pubmed:authorpubmed-author:MutaKKlld:pubmed
pubmed-article:1758053pubmed:authorpubmed-author:SadamuraSSlld:pubmed
pubmed-article:1758053pubmed:issnTypePrintlld:pubmed
pubmed-article:1758053pubmed:volume32lld:pubmed
pubmed-article:1758053pubmed:geneSymbolc-myclld:pubmed
pubmed-article:1758053pubmed:ownerNLMlld:pubmed
pubmed-article:1758053pubmed:authorsCompleteYlld:pubmed
pubmed-article:1758053pubmed:pagination1458-62lld:pubmed
pubmed-article:1758053pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1758053pubmed:meshHeadingpubmed-meshheading:1758053-...lld:pubmed
pubmed-article:1758053pubmed:meshHeadingpubmed-meshheading:1758053-...lld:pubmed
pubmed-article:1758053pubmed:meshHeadingpubmed-meshheading:1758053-...lld:pubmed
pubmed-article:1758053pubmed:meshHeadingpubmed-meshheading:1758053-...lld:pubmed
pubmed-article:1758053pubmed:meshHeadingpubmed-meshheading:1758053-...lld:pubmed
pubmed-article:1758053pubmed:meshHeadingpubmed-meshheading:1758053-...lld:pubmed
pubmed-article:1758053pubmed:meshHeadingpubmed-meshheading:1758053-...lld:pubmed
pubmed-article:1758053pubmed:meshHeadingpubmed-meshheading:1758053-...lld:pubmed
pubmed-article:1758053pubmed:year1991lld:pubmed
pubmed-article:1758053pubmed:articleTitle[A high serum level of interleukin-6 in a patient with aggressive multiple myeloma].lld:pubmed
pubmed-article:1758053pubmed:affiliationThird Department of Internal Medicine, Faculty of Medicine, Kyushu University.lld:pubmed
pubmed-article:1758053pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1758053pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:1758053pubmed:publicationTypeCase Reportslld:pubmed